Vapreotide

Revision as of 19:00, 7 April 2015 by Turky Alkathery (talk | contribs) (Created page with "{{Drugbox | IUPAC_name = 2-Amino-''N''-[10-(4-aminobutyl)-4-{[1-carbamoyl-2-(1''H''-indol-2-yl)ethyl]carbamoyl}-16-[(4-hydroxyphenyl)methyl]-13-(1''H''-indol-3-ylmethyl)-6,9,1...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Vapreotide
File:Vapreotide.svg
Clinical data
Trade namesSanvar
SynonymsOctastatin
ATC code
Pharmacokinetic data
Elimination half-life30 minutes
Identifiers
CAS Number
PubChem CID
PubChem SID
DrugBank
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC57H70N12O9S2
Molar mass1131.37 g/mol
3D model (JSmol)
Density1.4 g/cm3
Boiling point1,540.9 °C (2,805.62 °F)

Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea.[1]

References

Template:Pituitary and hypothalamic hormones and analogues


Template:Systemic-hormonal-drug-stub